Literature DB >> 25244776

[Effect of yupingfeng droppill in treatment of allergic rhinitis].

Hai-Yun Shi, Yan Zhuang, Xue-Yan Wang.   

Abstract

To evaluate the efficacy of Yupingfeng droppill and western medicine in treatment of allergic rhinitis, 76 patients from Beijing Shijitan hospital during April 2011 to May 2012 were selected and randomly divided into the treatment group (n = 44) and control group (n = 32). The treatment group was treated with Yupingfeng droppill and cetirizine tablets, the control group was treated with cetirizine tablets, the effect of the two groups was observed after 28 days, after treatment, the symptoms and inferior turbinate volume contrast of the two groups were better than before. The obvious effective rate and total effective rate were 84.09%, 95.45% and 46.87%, 56.25% in the treatment group and and control group. The differences in the obvious effective rate and total effective rate were statistically significant between two groups (P < 0.05), Yupingfeng droppill has the curative effect on allergic rhinitis, which is better than simple oral cetirizine tablets.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25244776

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  A network pharmacology-based approach to analyse potential targets of traditional herbal formulas: An example of Yu Ping Feng decoction.

Authors:  Huali Zuo; Qianru Zhang; Shibing Su; Qilong Chen; Fengqing Yang; Yuanjia Hu
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379

2.  Yupingfeng Pulvis Regulates the Balance of T Cell Subsets in Asthma Mice.

Authors:  Zhigang Wang; Xueting Cai; Zhonghua Pang; Dawei Wang; Juan Ye; Kelei Su; Xiaoyan Sun; Jing Li; Peng Cao; Chunping Hu
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-10       Impact factor: 2.629

Review 3.  Potential effectiveness of Chinese herbal medicine Yu ping feng san for adult allergic rhinitis: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Qiulan Luo; Claire Shuiqing Zhang; Lihong Yang; Anthony Lin Zhang; Xinfeng Guo; Charlie Changli Xue; Chuanjian Lu
Journal:  BMC Complement Altern Med       Date:  2017-11-06       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.